A Study of CDX-1307, in Patients With Incurable Breast, Colorectal, Pancreatic, Ovarian or Bladder Cancer (CDX 1307-01)

NCT00709462 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

Breast Cancer
Colorectal Cancer
Pancreatic Cancer
Bladder Cancer
Ovarian Cancer

Interventions

BIOLOGICAL: CDX1307

Sponsor

Celldex Therapeutics